AbbVie Failed To Study Risks Of AndroGel, Jury Told
AbbVie dodged its responsibility to test AndroGel to see whether users faced an increased risk of heart attack, attorneys for a man suing the company told an Illinois federal jury Monday...To view the full article, register now.
Already a subscriber? Click here to view full article